Evidence map›Paper›PMID 42140001›Full record

ArticleNeoplasia (New York, N.Y.)2026

Quantitative dissection of radioresistance in cancer cells: Oxygen depletion-induced biological versus chemical mechanisms and baseline mechanisms governed by HIF-1β-NRF2/TXNRD1.

Satoshi Takeuchi, Minoru Kobayashi, Peter Wai Tik Lee, Itsuki Takahashi, Toshitada Yoshihara, Hiroshi Harada

Abstract read
In one paragraph

Article in Neoplasia (New York, N.Y.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Satoshi TakeuchiLaboratory of Cancer Cell Biology, Graduate School of Biostudies, Kyoto University, Kyoto 606-8501, Japan.
Minoru KobayashiLaboratory of Cancer Cell Biology, Graduate School of Biostudies, Kyoto University, Kyoto 606-8501, Japan; Department of Genome Repair Dynamics, Radiation Biology Center, Graduate School of Biostudies, Kyoto University, Kyoto 606-8501, Japan.
Peter Wai Tik LeeLaboratory of Cancer Cell Biology, Graduate School of Biostudies, Kyoto University, Kyoto 606-8501, Japan.
Itsuki TakahashiLaboratory of Cancer Cell Biology, Graduate School of Biostudies, Kyoto University, Kyoto 606-8501, Japan.
Toshitada YoshiharaDivision of Molecular Science, Graduate School of Science and Technology, Gunma University, Kiryu, Gunma 376‑8515, Japan.
Hiroshi HaradaLaboratory of Cancer Cell Biology, Graduate School of Biostudies, Kyoto University, Kyoto 606-8501, Japan; Department of Genome Repair Dynamics, Radiation Biology Center, Graduate School of Biostudies, Kyoto University, Kyoto 606-8501, Japan. Electronic address: harada.hiroshi.5e@kyoto-u.ac.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The oxygen environment within malignant solid tumors is highly heterogeneous, with anoxic regions arising where oxygen supply is insufficient. It is known that oxygen depletion is one of the most influential factors that confer radioresistance on cancer cells. The resistance under low oxygen conditions has been attributed to both hypoxia-inducible genes-dependent biological mechanisms and genes-independent chemical mechanisms resulting from reduced production of radiation-induced reactive oxygen species. However, the relative contributions of these mechanisms have remained unclear. Moreover, although hypoxia-inducible factors (HIFs) are suggested to play key roles in hypoxia-inducible genes-dependent biological mechanisms, it has remained uncertain whether and how HIFs affect the intrinsic radioresistance of cancer cells. Here, we developed an approach to separately analyze the mechanisms behind radioresistance under anoxia as either hypoxia-inducible genes-dependent biological or genes-independent chemical mechanisms and found that the relative contributions in HeLa cells were 64.4 ± 9.06% and 35.6 ± 4.32%, respectively. In addition, HIF-1β alone, rather than heterodimeric HIF-1, HIF-2, or HIF-1β/AhR, was found to enhance the baseline radioresistance of cancer cells, irrespective of oxygen availability. RNA-sequencing-based screening further identified NRF2 and TXNRD1 as downstream effectors of HIF-1β underlying this baseline radioresistance. Taken together, these findings delineate the quantitative contributions of distinct mechanisms and identify HIF-1β-mediated signaling as a key determinant of baseline radioresistance, providing a framework for understanding how oxygen availability shapes tumor radioresistance and, in turn, a basis for developing strategies to overcome it.

Indexed as

NeoplasmsNF-E2-Related Factor 2OxygenRadiation ToleranceBasic Helix-Loop-Helix ProteinsCell HypoxiaCell Line, TumorGene Expression Regulation, NeoplasticHumansReactive Oxygen SpeciesSignal TransductionBasic Helix-Loop-Helix ProteinsNFE2L2 protein, humanNF-E2-Related Factor 2OxygenReactive Oxygen SpeciesAnoxiaAntioxidant capacityHIF-1β (ARNT)Reactive oxygen species (ROS)Tumor radioresistance

Identifiers

PMID42140001
PMCPMC13199936

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.